Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA grants fast track designation to Genervon's GM-604 in ALS

June 27, 2013

QRxPharma provides update on MoxDuo NDA review

June 27, 2013

Boehringer Ingelheim designs novel mGlu5 receptor modulators

June 27, 2013

Avanir's Nuedexta approved by the European Commission for pseudobulbar affect

June 26, 2013

Novartis prepares novel HDAC4 inhibitors

June 21, 2013

FDA issues drug safety communication for Zyprexa Relprevv

June 20, 2013

Researchers at Roche disclose new LRRK2 inhibitors

June 20, 2013

Sarepta Therapeutics reports updated 84-week data from phase IIb eteplirsen study

June 20, 2013

FDA accepts RHB-103 NDA for review

June 20, 2013

Oxygen Biotherapeutics gives update on Oxycyte

June 19, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...